TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types

BACKGROUND: Strategies are needed to coordinately block drivers and induce suppressors of cancer to reduce incidence and improve outcomes for individuals with inherited or acquired risk. We previously reported the chemopreventive and therapeutic efficacy of the combination of progestin and calcitrio...

Descripción completa

Detalles Bibliográficos
Autores principales: Paucarmayta, Ana, Taitz, Hannah, Casablanca, Yovanni, Rodriguez, Gustavo C., Maxwell, G. Larry, Darcy, Kathleen M., Syed, Viqar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798038/
https://www.ncbi.nlm.nih.gov/pubmed/35116885
http://dx.doi.org/10.21037/tcr.2019.07.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798038/
https://www.ncbi.nlm.nih.gov/pubmed/35116885
http://dx.doi.org/10.21037/tcr.2019.07.36

Ejemplares similares